Abbott Laboratories (ABT) operating KPIs
ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)
Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%
Abbott Laboratories quarterly Common Dividend Declared ($/share) ($)
Form 8-K Earnings Releases
Latest, Q3 2026
0.63
Period ended Sep 30, 2026
Change on a year earlier
+6.8%
0.59 in Q3 2025
History
31 quarters
Since Q1 2016
Sources
31
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up quarterly common dividend declared ($/share)
Cite this data
StockData. (2026). Abbott Laboratories Quarterly Common Dividend Declared ($/share) ($), quarterly Q1 2016–Q3 2026 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/div-quarterly-dps
See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.